Detalles de la búsqueda
1.
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 2023 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37573987
2.
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
Am J Gastroenterol
; 116(4): 723-732, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33982942
3.
Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.
Liver Transpl
; 18(10): 1209-16, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22740290
4.
Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA).
Viruses
; 14(12)2022 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36560672
5.
Impact of specialized multidisciplinary care on cirrhosis outcomes and acute care utilization.
Can Liver J
; 4(1): 38-50, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35991472
6.
Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD).
NPJ Vaccines
; 6(1): 9, 2021 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33431890
7.
The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience.
Can J Gastroenterol
; 24(1): 40-6, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20186355
8.
A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation.
Am J Gastroenterol
; 104(7): 1700-6, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19471253
9.
The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study.
Liver Int
; 29(2): 169-74, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18492024
10.
Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study.
Liver Int
; 29(7): 1110-5, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19490420
11.
Impact of Implementing a "FIB-4 First" Strategy on a Pathway for Patients With NAFLD Referred From Primary Care.
Hepatol Commun
; 3(10): 1322-1333, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31592044
12.
Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study.
Exp Clin Transplant
; 17(1): 59-63, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29619910
13.
Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network.
CMAJ Open
; 7(4): E610-E617, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31641059
14.
Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.
Can Liver J
; 1(4): 156-217, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-35992619
15.
De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.
Transplantation
; 83(9): 1162-8, 2007 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17496530
16.
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
Transplantation
; 100(5): 1059-65, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26950722
17.
Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis.
PLoS One
; 8(6): e68308, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23840845
18.
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.
Can J Gastroenterol
; 26(12): 917-38, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23248795
19.
MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease.
World J Hepatol
; 3(6): 157-63, 2011 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21860675
20.
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus.
Liver Int
; 25(4): 723-7, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15998421